SynthesisOncoimmunology2020

Efficacy and safety of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC): a systematic literature review.

Gernot Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.